APA

Hickman J. A., Stevens M. F., Gibson N. W., Langdon S. P., Fizames C., Lavelle F., Atassi G., Lunt E. & Tilson R. M. (19850809). Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. : Cancer research.

Chicago

Hickman J A, Stevens M F, Gibson N W, Langdon S P, Fizames C, Lavelle F, Atassi G, Lunt E and Tilson R M. 19850809. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. : Cancer research.

Harvard

Hickman J. A., Stevens M. F., Gibson N. W., Langdon S. P., Fizames C., Lavelle F., Atassi G., Lunt E. and Tilson R. M. (19850809). Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. : Cancer research.

MLA

Hickman J A, Stevens M F, Gibson N W, Langdon S P, Fizames C, Lavelle F, Atassi G, Lunt E and Tilson R M. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. : Cancer research. 19850809.